Biotech/Biomedical
News Category

Quantum BioPharma's Unbuzzd Draws Men's Fitness Attention as Placebo-Controlled Trial Shows Early Promise
Quantum BioPharma's unbuzzd supplement, designed to support alcohol metabolism, has been highlighted by Men's Fitness after a small placebo-controlled...

Helus Pharma CEO to Present at Guggenheim Healthcare Innovation Conference
Helus Pharma's CEO Michael Halstead will participate in a fireside chat at the Guggenheim Healthcare Innovation Conference, highlighting the company's...

Kairos Pharma's ENV-105 Shows Significant Survival Benefit in Prostate Cancer Trial
Kairos Pharma's ENV-105 demonstrated a statistically significant improvement in progression-free survival for metastatic castration-resistant prostate...

Ultrasound Method Opens New Front in Glioblastoma Fight as Drugmakers Race for Brain Cancer Therapies
University of Virginia researchers have developed an experimental ultrasound-based technique to deliver therapeutic nanoparticles into the brain to fi...

HeartBeam Sets Q3 2026 Earnings Call, ALIGN-ACS Data in Focus
HeartBeam will report third-quarter 2026 financial results on November 12, with management updates expected on the ALIGN-ACS pilot study and the compa...

Earth Science Tech Leverages 'Conglomerate' Model to Capture Outsourced Margins
Earth Science Tech's vertically integrated conglomerate model allows it to retain profit margins that competitors typically outsource, positioning it ...

Stroke Neurology Leader Bruce Ovbiagele to Receive 2026 Eugene Braunwald Academic Mentorship Award
Dr. Bruce Ovbiagele, a leading stroke neurologist and mentor, will receive the American Heart Association's 2026 Eugene Braunwald Academic Mentorship ...

New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer
A new expert consensus published in the World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical management of unilatera...

SS Innovations Shows Remote Robotic Heart Surgery Across 7,500 Miles
SS Innovations demonstrated long-distance robotic cardiac and other surgeries at October conferences, signaling a potential path to extending speciali...

Adaptogenics Health Corp. Pushes for Supply Chain Verification as Peptide Market Moves Toward Regulation
Adaptogenics Health Corp. is building its peptide strategy around supply verification and traceability as U.S. regulators advance an interim access po...

Quantum BioPharma's Unbuzzd Draws Men's Fitness Spotlight as Trial Shows Early Promise
Quantum BioPharma's unbuzzd supplement drink, designed to support alcohol metabolism, has drawn attention from Men's Fitness after a clinical trial sh...

HeartBeam's ALIGN-ACS Pilot Study Shows Higher Specificity Than Standard ECG for Heart Attack Assessment
HeartBeam's ALIGN-ACS pilot study demonstrated its portable, cable-free ECG technology achieved higher specificity than standard 12-lead ECGs for acut...

Mayo Clinic Study Finds Brain Tumor DNA in Cerebrospinal Fluid, Opening Door to Less Invasive Diagnosis
A Mayo Clinic study has found that cerebrospinal fluid contains DNA from complex brain tumors, potentially enabling less invasive diagnosis and monito...

ABVC BioPharma Closes $3.39 Million Private Placement to Fund Operations and Settle Lind Global Claim
ABVC BioPharma's $3.39 million private placement of original issue discount senior convertible notes will fund working capital, subsidiary development...

tZERO to Go Public via SPAC Merger with FG Imperii, Valuing Tokenization Infrastructure at $350 Million
tZERO Group, Inc. will become a publicly traded company through a business combination with FG Imperii Acquisition Corp., aiming to scale its regulate...

Large Long-Term Study Finds Modern Hormone Replacement Therapy Not Linked to Heart Disease Risk
A study of over 52,000 women in Israel found that contemporary hormone replacement therapy did not increase the risk of heart attack, stroke, blood cl...

Tonix Taps George Lederman to Lead AI and Strategy, Oversee Business Development
Tonix Pharmaceuticals appoints George Lederman as EVP of strategy and transformation to drive AI initiatives and business development, a move that cou...

AI Plus Wearables May Flag Hypertensive Crisis Up to Three Days Early, Preliminary Study Finds
Preliminary research presented at the American Heart Association's Scientific Sessions 2026 suggests that AI analysis of data from a portable cuff-bas...

Okogen Doses First Patient in EMERALD Trial of Treyegen for Acute Infectious Conjunctivitis
Okogen has dosed the first patient in its Phase 1/2 EMERALD Trial of Treyegen, a potential single therapy for acute infectious conjunctivitis, marking...

Heart Valve Disease Deaths Rise Among Older U.S. Adults, Reversing Decades of Decline
New preliminary research shows that death rates from valvular heart disease among U.S. adults 65 and older have increased since 2018 and are projected...

Survey Finds Most Clinics Screen for Heart, Kidney and Metabolic Risks, but Few Use Newer Assessment Tools
A new survey of 97 U.S. clinical sites finds that while most screen for cardiovascular-kidney-metabolic risk factors, fewer than one-third use newer s...

AI-Guided Heart Scans in Mobile Units Show Promise for Rural Care
Preliminary research presented at the American Heart Association's Scientific Sessions 2026 found that non-specialists using AI guidance in mobile uni...

Retired NFL Linemen Face High Rates of Hidden Artery Plaque, Study Finds
Preliminary research presented at the American Heart Association's Scientific Sessions 2026 reveals that most retired NFL players, particularly lineme...

NPI Taps Former Walmart Sourcing Director Hemant Agrahari as President
Nutritional Products International has appointed former Walmart sourcing executive Hemant Agrahari as President to lead retail strategy and brand onbo...

Energy Drinks and Stimulant Supplements Linked to Cardiac Arrest and Heart Attack in Young Adults, Study Finds
A new analysis of FDA adverse-event reports links caffeinated energy drinks and stimulant supplements to serious cardiovascular events, especially in ...

GLP-1 Medications Outperform Metformin in Preventing Diabetes and Heart Events, Preliminary Study Finds
Preliminary research presented at the American Heart Association's Scientific Sessions 2026 suggests GLP-1 medications may reverse prediabetes and red...

New Estimate Puts Nonmelanoma Skin Cancer Diagnoses at 4.7 Million a Year, 42 Percent Above Long-Cited Figure
A new analysis by SkinCure Oncology estimates that 4.7 million Americans are diagnosed with nonmelanoma skin cancer annually, sharply revising a decad...

San Antonio's 'Hidden Giant' Status Threatens Global Investment, Innovation Leader Warns
Dr. Lina Rugova warns that San Antonio's low international profile is costing the city investment and talent, and outlines a strategy to market its ad...

OPH Health Founder Leona Tong Named to 2026 Forbes China 100 Most Influential Chinese
Leona Tong, founder and CEO of Singapore-based OPH Health, was selected for the 2026 Forbes China 100 Most Influential Chinese Selection, highlighting...

Beijing Forum Pushes Evidence-Based Medicine Into Traditional Chinese Medicine's Mainstream
Experts from 14 countries gathered at Beijing University of Chinese Medicine to debate how rigorous evidence can validate traditional Chinese medicine...

A Free Five-Question Checklist Aims to Make Early No-Go Calls in Biotherapeutics a Success, Not a Setback
Catherine Cifuentes-Rojas, a biotherapeutics veteran now at Ginkgo Bioworks, has released a free five-question go/no-go checklist to help discovery te...

Market Street Capital Targets Healthcare Financing as Reimbursement Cuts Loom
Market Street Capital is positioning itself to help middle-market healthcare companies secure financing amid looming Medicare reimbursement cuts and h...

VERAXA Biotech Expands Human-Relevant Testing to Advance BiTAC Cancer Therapies
VERAXA Biotech is expanding its use of human-relevant preclinical testing methods, including 3D tumor spheroid and patient-derived tumor models, to im...

Quantum BioPharma Taps Thermo Fisher for Phase 2 Lucid-MS Trial in Progressive MS
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to advance its Phase 2 trial of Luc...

Dual-Targeting Antibody Shows Promise Against Multiple Tumor Types in Preclinical Study
A preclinical study of a dual-impact antibody that combats multiple tumor types in mice could widen the reach of immunotherapy, which has had profound...

SS Innovations Demonstrates Long-Distance Robotic Cardiac Surgery, Advancing Remote Care
SS Innovations showcased its SSi Mantra system in remote robotic cardiac and other surgeries across 7,500 miles, highlighting the potential to extend ...

FDA Loosens Peptide Rules, Opening New Doors for Adaptogenics Health
The FDA's decision to allow compounding pharmacies to produce six previously restricted peptides could reshape the peptide therapy market and benefit ...

Federal Policy Opens Door to Compounded Peptides, Reshaping Regulatory Landscape for Adaptogenics and Industry
A new federal policy allowing licensed pharmacies and physicians to compound six previously restricted peptides without FDA enforcement action could l...

Neurologist Says Brain May Be Driving Chronic Back Pain as New Data Shows Relief
Lin Health's Dr. Eric Anderson highlights central sensitization as a key driver of chronic back pain, citing new research showing its program reduced ...

Lapp Wagons Expands Speedway Express Line Nationwide with Free Shipping
Lapp Wagons LLC now ships its Speedway Express kid wagons, work wagons, and aftermarket wagon wheels nationwide at no additional cost, extending the r...

Helix BioPharma Narrows Fiscal 2026 Loss to $3.35 Million but Warns of Severe Liquidity Crunch
Helix BioPharma Corp. reported a reduced net loss of $3.35 million for fiscal 2026 but disclosed a working capital deficiency and cash reserves insuff...

Regentis Biomaterials' GelrinC Shows Promise in Cartilage Repair Market
Regentis Biomaterials is advancing its GelrinC cartilage repair technology with strong clinical data and regulatory progress, targeting a significant ...

Regentis Biomaterials' GelrinC Shows Promise in Cartilage Repair as Company Eyes FDA Approval
Regentis Biomaterials is advancing its GelrinC hydrogel implant for knee cartilage repair, with strong clinical data and a CE mark in Europe, as it pr...

Annovis Bio CEO to Present at Two November Biotechnology Conferences
Annovis Bio CEO Maria Maccecchini will present at two November biotechnology conferences, highlighting the company's clinical programs for Alzheimer's...

Oncotelic Advances PLA Toward 100 Billion Protein Vectors After Liver Cancer Study Validation
Oncotelic Therapeutics is scaling its PLA-guided discovery engine toward a 100-billion-vector protein program after a published liver cancer study val...

TransCode Therapeutics Launches Strategic Review to Maximize Value of Oncology Portfolio
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential licensing, partnerships, ...